Lender's $13M Atty Fee Reserve Bid In Eiger Ch. 11 Plan Nixed

By Clara Geoghegan · August 20, 2024, 7:52 PM EDT

A Texas bankruptcy judge on Tuesday mostly sided with life science company Eiger BioPharmaceuticals in estimating a secured lender's future claims, saying at a hearing that Eiger's Chapter 11 reserve for...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Case Information

Case Title

Eiger BioPharmaceuticals, Inc.

Case Number

Court

Texas Northern

Nature of Suit

Date Filed

April 01, 2024

Recent Articles By Clara

October 31, 2024
The Story Behind American Tire's Chapter 22 Bankruptcy
October 30, 2024
Toolmaker Hardinge Cleared To Send Ch. 11 Plan For A Vote
October 30, 2024
Canadian Lender Seeks Ch. 15 With Wind-Down Or Sale Plans
October 29, 2024
NS8 Litigation Trustee Seeks $173M From Ex-Exec For Fraud
October 29, 2024
Tech Co. Launches Consumer Bankruptcy Payment Portal
October 28, 2024
Attys Seek $48M Fees For Hooking $152M In Tuna Fixing Deals
October 25, 2024
Biolase Can't Hire Its Outside GC In Ch. 11, US Trustee Says
October 24, 2024
ConvergeOne Can't Ax Snubbed Creditors' Ch. 11 Plan Appeal
October 23, 2024
Del. Judge Won't Yet Revisit $242K Atty Sanctions In Ch. 7
October 22, 2024
How Online Creditor Groups Are Shaping Major Bankruptcies